Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study (2005)
- Autores:
- Autores USP: ELKIS, HELIO - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- Assuntos: POLIMORFISMO; CÉREBRO; ESQUIZOFRENIA (TERAPIA); FÁRMACOS (SISTEMA NERVOSO CENTRAL) (EFEITOS ADVERSOS); PSICOSE EM ADULTO (ETIOLOGIA)
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Schizophrenia bulletin
- ISSN: 0586-7614
- Volume/Número/Paginação/Ano: v. 31, n. 2, p. 404, 2005
- Nome do evento: International Congress on Schizophrenia Research
-
ABNT
SALLET, P. C. et al. Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study. Schizophrenia bulletin. Rockville: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://schizophreniabulletin.oxfordjournals.org/content/31/2/183.full.pdf+html. Acesso em: 26 abr. 2024. , 2005 -
APA
Sallet, P. C., Helkis, H., Alves, T. M., Henna, J. N., Oliveira, J. R., Campi de Castro, C., et al. (2005). Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study. Schizophrenia bulletin. Rockville: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://schizophreniabulletin.oxfordjournals.org/content/31/2/183.full.pdf+html -
NLM
Sallet PC, Helkis H, Alves TM, Henna JN, Oliveira JR, Campi de Castro C, Busatto GF, Gattaz WF. Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study [Internet]. Schizophrenia bulletin. 2005 ; 31( 2): 404.[citado 2024 abr. 26 ] Available from: http://schizophreniabulletin.oxfordjournals.org/content/31/2/183.full.pdf+html -
Vancouver
Sallet PC, Helkis H, Alves TM, Henna JN, Oliveira JR, Campi de Castro C, Busatto GF, Gattaz WF. Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study [Internet]. Schizophrenia bulletin. 2005 ; 31( 2): 404.[citado 2024 abr. 26 ] Available from: http://schizophreniabulletin.oxfordjournals.org/content/31/2/183.full.pdf+html - Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
- Decreased S100-beta protein in schizophrenia: preliminary evidence
- Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study
- Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability
- A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia
- Leonhard´s classification of Schizophrenias and MRI brain abnormalities: preliminary results
- Niacin test in schizophrenia and in major depression
- Algumas recomendações para estudos com placebo
- Esquizofrenia e gênero
- Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
